Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma

[1]  T. Roques,et al.  Ipsilateral neck radiotherapy in N2b well‐lateralized tonsil cancer – Approach with caution , 2019, Head & neck.

[2]  J. Waldron,et al.  Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer. , 2019, International journal of radiation oncology, biology, physics.

[3]  W. Hicks,et al.  Patients Report Less Severe Symptoms With Unilateral Radiation Therapy Than Bilateral Radiation Therapy for Tonsillar Squamous Cell Carcinomas , 2018 .

[4]  W. Thorstad,et al.  Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil , 2017, Cancer.

[5]  D. Sher,et al.  Risk of contralateral nodal failure following ipsilateral IMRT for node-positive tonsillar cancer. , 2017, Oral oncology.

[6]  A. Al-Mamgani,et al.  Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review. , 2017, Cancer treatment reviews.

[7]  E. Sturgis,et al.  Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. , 2017, Practical radiation oncology.

[8]  J. Waldron,et al.  Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. , 2017, International journal of radiation oncology, biology, physics.

[9]  M. Urken,et al.  Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization , 2017, Head & neck.

[10]  R. Fisher,et al.  Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART). , 2017, International journal of radiation oncology, biology, physics.

[11]  W. Mendenhall,et al.  Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil , 2016, European Archives of Oto-Rhino-Laryngology.

[12]  A. Eisbruch,et al.  Matted nodes: High distant‐metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus–related oropharyngeal cancer , 2016, Head & neck.

[13]  A. Eisbruch,et al.  Matted nodes as a predictor of distant metastasis in advanced‐stage III/IV oropharyngeal squamous cell carcinoma , 2016, Head & neck.

[14]  A. Garden,et al.  Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  N. Hockstein,et al.  Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach. , 2015, Oral oncology.

[16]  S. Bhide,et al.  Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. , 2014, Oral oncology.

[17]  L. Peters,et al.  Tonsillar cancer: The Peter MacCallum experience with unilateral and bilateral irradiation , 2014, Head & neck.

[18]  Hong-Gyun Wu,et al.  Long-term results of ipsilateral radiotherapy for tonsil cancer , 2013, Radiation oncology journal.

[19]  A. Garden,et al.  Unilateral radiotherapy for the treatment of tonsil cancer. , 2012, International journal of radiation oncology, biology, physics.

[20]  A. Raben,et al.  Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. , 2009, International journal of radiation oncology, biology, physics.

[21]  C. Grau,et al.  Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[23]  P. Levendag,et al.  Unilateral neck irradiation for well-lateralized oropharyngeal cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  P. Fayers,et al.  Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[26]  C. Cleeland,et al.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. , 2000, Cancer.